Ilan Ben‐Zvi

2.7k total citations · 1 hit paper
77 papers, 1.9k citations indexed

About

Ilan Ben‐Zvi is a scholar working on Molecular Biology, Immunology and Nephrology. According to data from OpenAlex, Ilan Ben‐Zvi has authored 77 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 23 papers in Immunology and 19 papers in Nephrology. Recurrent topics in Ilan Ben‐Zvi's work include Inflammasome and immune disorders (36 papers), Gout, Hyperuricemia, Uric Acid (13 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (9 papers). Ilan Ben‐Zvi is often cited by papers focused on Inflammasome and immune disorders (36 papers), Gout, Hyperuricemia, Uric Acid (13 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (9 papers). Ilan Ben‐Zvi collaborates with scholars based in Israel, United States and Italy. Ilan Ben‐Zvi's co-authors include Avi Livneh, Shaye Kivity, Pnina Langevitz, Yehuda Shoenfeld, Chagai Grossman, Gil Bornstein, Merav Lidar, Olga Kukuy, Olga Feld and Betty Diamond and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Scientific Reports.

In The Last Decade

Ilan Ben‐Zvi

76 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hydroxychloroquine: From Malaria to Autoimmunity

2011 455 citations Ilan Ben‐Zvi, Shaye Kivity et al. profile →

Peers

Ilan Ben‐Zvi

IMMUN

RHEUM

NEPHR

SURGE

Ana Tobar Israel

George Bayliss United States

Marcello Rattazzi Italy

Yuji Nozaki Japan

Xin J. Zhou United States

Hidekazu Ikeuchi Japan

Dominique Guerrot France

Pier Paolo Sainaghi Italy

Nicole D. Zantek United States

Vir Singh Negi India

Ana Tobar Israel

Ilan Ben‐Zvi

645 ×0.7

274 ×0.5

IMMUN

369 ×0.9

RHEUM

399 ×1.5

NEPHR

293 ×1.3

SURGE

Citations per year, relative to Ilan Ben‐Zvi Ilan Ben‐Zvi (= 1×) peers Ana Tobar

Countries citing papers authored by Ilan Ben‐Zvi

Since Specialization

Citations

This map shows the geographic impact of Ilan Ben‐Zvi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilan Ben‐Zvi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilan Ben‐Zvi more than expected).

Fields of papers citing papers by Ilan Ben‐Zvi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ilan Ben‐Zvi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilan Ben‐Zvi. The network helps show where Ilan Ben‐Zvi may publish in the future.

Co-authorship network of co-authors of Ilan Ben‐Zvi

This figure shows the co-authorship network connecting the top 25 collaborators of Ilan Ben‐Zvi. A scholar is included among the top collaborators of Ilan Ben‐Zvi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ilan Ben‐Zvi. Ilan Ben‐Zvi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Goldman, Adam, et al.. (2024). Adverse cardiovascular events in rheumatoid arthritis patients treated with JAK inhibitors: An analysis of postmarketing spontaneous safety reports. Seminars in Arthritis and Rheumatism. 67. 152461–152461. 13 indexed citations

Goldman, Adam, Emanuel Raschi, Amit Druyan, et al.. (2024). Gastrointestinal Perforations Associated With JAK Inhibitors: A Disproportionality Analysis of the FDA Adverse Event Reporting System. United European Gastroenterology Journal. 13(4). 566–575. 3 indexed citations

Goldman, Adam, Boris Fishman, Gilad Twig, et al.. (2023). The real-world safety profile of sodium-glucose co-transporter-2 inhibitors among older adults (≥ 75 years): a retrospective, pharmacovigilance study. Cardiovascular Diabetology. 22(1). 16–16. 24 indexed citations

Ben‐Zvi, Ilan, et al.. (2022). Screening for Fabry’s disease in a high-risk subpopulation of FMF. European journal of medical research. 27(1). 210–210.

Brenner, Ronen, Yael Shinar, Asaf Shemer, et al.. (2022). Determining the origin of different variants associated with familial mediterranean fever by machine-learning. Scientific Reports. 12(1). 15206–15206. 3 indexed citations

Goldman, Adam, Emanuel Raschi, Tali Cukierman‐Yaffe, et al.. (2021). Hyperglycaemic disorders associated with PCSK9 inhibitors: a real-world, pharmacovigilance study. European Journal of Preventive Cardiology. 29(9). 1334–1342. 25 indexed citations

Yahia, Soad Haj, Ilan Ben‐Zvi, Merav Lidar, & Avi Livneh. (2021). Familial Mediterranean fever (FMF)-response to TNF-blockers used for treatment of FMF patients with concurrent inflammatory diseases. Joint Bone Spine. 88(5). 105201–105201. 6 indexed citations

Kukuy, Olga, Batia Kaplan, Alexander Volkov, et al.. (2019). Kidney disease and plasma cell dyscrasias: ambiguous cases solved by serum free light chain dimerization analysis. Clinical and Experimental Nephrology. 23(6). 763–772. 3 indexed citations

Grossman, Chagai, et al.. (2019). Efficacy and safety of long-term treatment with intravenous colchicine for familial Mediterranean fever (FMF) refractory to oral colchicine. Rheumatology International. 39(3). 517–523. 10 indexed citations

10.

Amarilyo, Gil, Nir Pillar, Ilan Ben‐Zvi, et al.. (2018). Analysis of microRNAs in familial Mediterranean fever. PLoS ONE. 13(5). e0197829–e0197829. 26 indexed citations

11.

Bornstein, Gil, et al.. (2018). Hematological malignancies mimicking rheumatic syndromes: case series and review of the literature. Rheumatology International. 38(9). 1743–1749. 7 indexed citations

12.

Kaplan, Batia, et al.. (2017). Immunoglobulin free light chains in saliva: a potential marker for disease activity in multiple sclerosis. Clinical & Experimental Immunology. 192(1). 7–17. 10 indexed citations

13.

Yahia, Soad Haj, Ilan Ben‐Zvi, & Avi Livneh. (2017). Colchicine intoxication in familial Mediterranean fever patients using clarithromycin for the treatment of Helicobacter pylori: a series of six patients. Rheumatology International. 38(1). 141–147. 14 indexed citations

14.

Ben‐Zvi, Ilan & Avi Livneh. (2014). Colchicine failure in familial Mediterranean fever and potential alternatives: embarking on the anakinra trial.. PubMed. 16(5). 271–3. 18 indexed citations

15.

Ben‐Zvi, Ilan, et al.. (2014). Colchicine-free remission in familial Mediterranean fever: featuring a unique subset of the disease-a case control study. Orphanet Journal of Rare Diseases. 9(1). 3–3. 22 indexed citations

16.

Ben‐Zvi, Ilan, et al.. (2012). Risk factors for amyloidosis and impact of kidney transplantation on the course of familial Mediterranean fever.. PubMed. 14(4). 221–4. 11 indexed citations

17.

Ben‐Zvi, Ilan & Avi Livneh. (2012). The Israeli Annual FMF, Amyloidosis and Other Autoinflammatory Diseases Meeting (July 2011): a bridge spanning these entities.. PubMed. 14(4). 219–20. 1 indexed citations

18.

Ben‐Zvi, Ilan & Avi Livneh. (2010). Chronic inflammation in FMF: markers, risk factors, outcomes and therapy. Nature Reviews Rheumatology. 7(2). 105–112. 183 indexed citations

19.

Ben‐Zvi, Ilan, Cynthia Aranow, Meggan Mackay, et al.. (2010). The Impact of Vitamin D on Dendritic Cell Function in Patients with Systemic Lupus Erythematosus. PLoS ONE. 5(2). e9193–e9193. 133 indexed citations

20.

Ben‐Zvi, Ilan, et al.. (2006). Effects of Diabetes Mellitus, Chronic Renal Failure and Hemodialysis on Serum and Salivary Antioxidant Status. Nephron Clinical Practice. 105(3). c114–c120. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact